☆ 4.7 Article

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

ANNALS OF ONCOLOGY (2010)

期刊

ANNALS OF ONCOLOGY

卷 21, 期 -, 页码 v41-v45

出版社

OXFORD UNIV PRESS

DOI: 10.1093/annonc/mdq245

关键词

-

类别

Oncology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Oncology

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer

R. Kanesvaran, E. Castro, A. Wong, K. Fizazi, M. L. K. Chua, Y. Zhu, H. Malhotra, Y. Miura, J. L. Lee, F. L. T. Chong, Y-S Pu, C-C Yen, M. Saad, H. J. Lee, H. Kitamura, K. Prabhash, Q. Zou, G. Curigliano, E. Poon, S. P. Choo, S. Peters, E. Lim, T. Yoshino, G. Pentheroudakis

Summary: To accommodate the specific requirements of prostate cancer treatment in Asia, a special meeting was convened by ESMO and SSO to revise the guidelines published in 2020. These guidelines represent the consensus opinions of prostate cancer treatment experts from Asian countries and aim to provide optimization and harmonization recommendations for the management of prostate cancer patients across different regions in Asia.

ESMO OPEN (2022)

添加到收藏夹

Article Oncology

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer

T. Yoshino, G. Argiles, E. Oki, E. Martinelli, H. Taniguchi, D. Arnold, Mishima, Y. Li, B. K. Smruti, J. B. Ahn, I. Faud, C. E. Chee, K. -h. Yeh, P. -c. Lin, C. Chua, H. H. Hasbullah, M. A. Lee, A. Sharma, Y. Sun, G. Curigliano, H. Bando, F. Lordick, T. Yamanaka, J. Tabernero, E. Baba, A. Cervantes, A. Ohtsu, S. Peters, C. Ishioka, G. Pentheroudakis

Summary: The ESMO 2020 guidelines for localised colon cancer were adapted to account for ethnic differences in Asian patients during a special virtual meeting convened by ESMO and JSMO in March 2021. These guidelines represent the consensus opinions of experts from various oncological societies in Asia, and the voting was based on scientific evidence.

ANNALS OF ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer

S. Koppikar, A. Oaknin, K. Govind Babu, D. Lorusso, S. Gupta, L. -Y. Wu, W. Rajabto, K. Harano, S. -h. Hong, R. A. Malik, H. Strebel, I. M. Aggarwal, C. -H. Lai, T. Dejthevaporn, S. Tangjitgamol, W. F. Cheng, W. Y. Chay, D. Benavides, N. M. Hashim, Y. W. Moon, M. Yunokawa, T. D. Anggraeni, W. Wei, G. Curigliano, A. Maheshwari, U. Mahantshetty, S. Sheshadri, S. Peters, T. Yoshino, G. Pentheroudakis

Summary: The European Society for Medical Oncology (ESMO) published the most recent version of their guidelines for endometrial cancer in 2022. In order to account for variations in endometrial cancer management in Asia, a virtual meeting was held in July 2022 to adapt the ESMO guidelines. The guidelines represent the consensus opinion of Asian experts from various oncological societies. The aim is to provide guidance for the management of endometrial cancer in different regions of Asia, considering variations in clinical presentation, diagnostic practices, and access to treatment options.

ESMO OPEN (2023)

添加到收藏夹

Article Oncology

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer

T. Yoshino, A. Cervantes, H. Bando, E. Martinelli, E. Oki, R. -H. Xu, N. A. Mulansari, K. Govind Babu, M. A. Lee, C. K. Tan, G. Cornelio, D. Q. Chong, L. -T. Chen, S. Tanasanvimon, N. Prasongsook, K. -H. Yeh, C. Chua, M. D. Sacdalan, W. J. Sow (Jenson), S. T. Kim, R. T. Chacko, R. A. Syaiful, S. Z. Zhang, G. Curigliano, S. Mishima, Y. Nakamura, H. Ebi, Y. Sunakawa, M. Takahashi, E. Baba, S. Peters, C. Ishioka, G. Pentheroudakis

Summary: The ESMO Guidelines for metastatic colorectal cancer (mCRC) were adapted to produce the Pan-Asian adapted (PAGA) ESMO consensus guidelines for Asian patients. The guidelines were developed by a panel of experts from Asian oncological societies, based on scientific evidence and independent of treatment practices and reimbursement decisions. The aim is to optimize and harmonize the management of mCRC across Asia, considering the differences in screening practices, molecular profiling, and drug approvals and reimbursement strategies.

ESMO OPEN (2023)

添加到收藏夹

Article Oncology

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma

R. Kanesvaran, C. Porta, A. Wong, T. Powles, Q. S. Ng, M. Schmidinger, D. Ye, H. Malhotra, Y. Miura, J. L. Lee, F. L. T. Chong, Y-S Pu, C-C Yen, M. Saad, H. J. Lee, H. Kitamura, G. S. Bhattacharyya, G. Curigliano, E. Poon, S. P. Choo, S. Peters, E. Lim, T. Yoshino, G. Pentheroudakis

Summary: The ESMO and SSO held a special virtual guidelines meeting in May 2021 to adapt the 2019 guidelines for renal cell carcinoma treatment to account for ethnic differences in Asian patients. Expert opinions from oncological societies in China, India, Japan, Korea, Malaysia, Singapore, and Taiwan were considered based on scientific evidence independent of current treatment practices and drug access restrictions in Asian countries.

ESMO OPEN (2021)

添加到收藏夹

Article Oncology

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

S. J. Strauss, A. M. Frezza, N. Abecassis, J. Bajpai, S. Bauer, R. Biagini, S. Bielack, J. Y. Blay, S. Bolle, S. Bonvalot, I Boukovinas, J. V. M. G. Bovee, K. Boye, B. Brennan, T. Brodowicz, A. Buonadonna, E. de Alava, A. P. Dei Tos, X. Garcia Del Muro, A. Dufresne, M. Eriksson, F. Fagioli, A. Fedenko, V Ferraresi, A. Ferrari, N. Gaspar, S. Gasperoni, H. Gelderblom, F. Gouin, G. Grignani, A. Gronchi, R. Haas, A. B. Hassan, S. Hecker-Nolting, N. Hindi, P. Hohenberger, H. Joensuu, R. L. Jones, C. Jungels, P. Jutte, L. Kager, B. Kasper, A. Kawai, K. Kopeckova, D. A. Krakorova, A. Le Cesne, F. Le Grange, E. Legius, A. Leithner, A. Lopez Pousa, J. Martin-Broto, O. Merimsky, C. Messiou, A. B. Miah, O. Mir, M. Montemurro, B. Morland, C. Morosi, E. Palmerini, M. A. Pantaleo, R. Piana, S. Piperno-Neumann, P. Reichardt, P. Rutkowski, A. A. Safwat, C. Sangalli, M. Sbaraglia, S. Scheipl, P. Schoffski, S. Sleijfer, D. Strauss, K. Sundby Hall, A. Trama, M. Unk, M. A. J. van de Sande, W. T. A. van der Graaf, W. J. van Houdt, T. Frebourg, R. Ladenstein, P. G. Casali, S. Stacchiotti

Summary: The paragraph lists the names of various researchers, possibly in the author list of a research paper.

ANNALS OF ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer

S. -A. Im, A. Gennari, Y. H. Park, J. H. Kim, Z. -F. Jiang, S. Gupta, T. H. Fadjari, K. Tamura, M. Y. Mastura, M. L. T. Abesamis-Tiambeng, E. H. Lim, C. -H. Lin, A. Sookprasert, N. Parinyanitikul, L. -M. Tseng, S. -C. Lee, P. Caguioa, M. Singh, Y. Naito, R. A. Hukom, B. K. Smruti, S. -S. Wang, S. B. Kim, K. -H. Lee, H. K. Ahn, S. Peters, T. W. Kim, T. Yoshino, G. Pentheroudakis, G. Curigliano, N. Harbeck

Summary: The most recent version of the ESMO Clinical Practice Guidelines for metastatic breast cancer was published in 2021. In 2022, a special hybrid guidelines meeting was held to adapt these guidelines to the Asian context, with input from Asian oncology societies. The aim is to provide harmonized management of MBC patients across Asia.

ESMO OPEN (2023)

添加到收藏夹

Article Oncology

Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck

B. Keam, J-P Machiels, H. R. Kim, L. Licitra, W. Golusinski, V Gregoire, Y. G. Lee, C. Belka, Y. Guo, S. J. Rajappa, M. Tahara, M. Azrif, M. K. Ang, M-H Yang, C-H Wang, Q. S. Ng, W. I. Wan Zamaniah, N. Kiyota, S. Babu, K. Yang, G. Curigliano, S. Peters, T. W. Kim, T. Yoshino, G. Pentheroudakis

Summary: ESMO and KSMO convened a special virtual guidelines meeting in July 2021 to adapt the ESMO 2020 guidelines to consider potential ethnic differences in Asian patients' treatment of SCCs of the head and neck. These guidelines represent consensus opinions from experts across Asia and provide expert recommendations for the diagnosis, treatment, and management of patients with SCC of the oral cavity, larynx, oropharynx, and hypopharynx.

ESMO OPEN (2021)

添加到收藏夹

Article Medicine, General & Internal

Anal Cancer-Diagnosis, Treatment and Follow-Up

Robert Siegel, Ricardo Niklas Werner, Stephan Koswig, Matthew Gaskins, Claus Roedel, Felix Aigner

Summary: The study provides detailed information on the development of the guidelines for the treatment of anal cancer. It recommends chemoradiotherapy as the standard treatment for stages II-III, with a suggestion against biopsy in complete clinical response. For stage IV anal cancer, there are only open recommendations, urging further research in this area.

DEUTSCHES ARZTEBLATT INTERNATIONAL (2021)

添加到收藏夹

Review Oncology

Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS)

Jose Alejandro Perez-Fidalgo, Eugenia Ortega, Jordi Ponce, Andres Redondo, Isabel Sevilla, Claudia Valverde, Josep Isern Verdum, Enrique de Alava, Mar Galera Lopez, Gloria Marquina, Ana Sebio

Summary: Uterine sarcomas are rare and diverse, making diagnosis, surgical management, and systemic treatment challenging; treatment decisions should involve a multidisciplinary tumor board; evidence is limited, often based on case series or clinical trials including these tumors with other soft tissue sarcomas. These guidelines summarize the relevant evidence on the diagnosis, staging, pathological disparities, surgical management, systemic treatment, and follow-up of uterine sarcomas.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis

Tetsuhide Ito, Toshihiko Masui, Izumi Komoto, Ryuichiro Doi, Robert Y. Osamura, Akihiro Sakurai, Masafumi Ikeda, Koji Takano, Hisato Igarashi, Akira Shimatsu, Kazuhiko Nakamura, Yuji Nakamoto, Susumu Hijioka, Koji Morita, Yuichi Ishikawa, Nobuyuki Ohike, Atsuko Kasajima, Ryoji Kushima, Motohiro Kojima, Hironobu Sasano, Satoshi Hirano, Nobumasa Mizuno, Taku Aoki, Takeshi Aoki, Takao Ohtsuka, Tomoyuki Okumura, Yasutoshi Kimura, Atsushi Kudo, Tsuyoshi Konishi, Ippei Matsumoto, Noritoshi Kobayashi, Nao Fujimori, Yoshitaka Honma, Chigusa Morizane, Shinya Uchino, Kiyomi Horiuchi, Masanori Yamasaki, Jun Matsubayashi, Yuichi Sato, Masau Sekiguchi, Shinichi Abe, Takuji Okusaka, Mitsuhiro Kida, Wataru Kimura, Masao Tanaka, Yoshiyuki Majima, Robert T. Jensen, Koichi Hirata, Masayuki Imamura, Shinji Uemoto

Summary: Neuroendocrine neoplasms (NENs) are rare tumors with diverse clinical manifestations. Accurate pathological classification and determination of tumor characteristics are crucial for selecting appropriate treatment strategies. The revised Clinical Practice Guidelines for Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs) provide comprehensive directions for the management of NENs, incorporating new evidence and updated concepts.

JOURNAL OF GASTROENTEROLOGY (2021)

添加到收藏夹

Article Oncology

SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)

Rosario Garcia-Campelo, Ivana Sullivan, Edurne Arriola, Amelia Insa, Oscar Juan Vidal, Patricia Cruz-Castellanos, Teresa Moran, Noemi Reguart, Jon Zugazagoitia, Manuel Domine

Summary: Small-cell lung cancer (SCLC) accounts for about 15% of lung cancers and is highly aggressive. Surgical resection followed by adjuvant therapy is curative for limited-stage SCLC, but only a minority of patients are eligible for surgery. Concurrent chemo-radiotherapy is the standard treatment for inoperable limited-stage SCLC, while combination chemotherapy with programmed death-ligand 1 inhibitors has become the new front-line standard for extensive-stage SCLC. Advances in understanding SCLC biology and new treatment approaches offer potential improvements in patient care.

CLINICAL & TRANSLATIONAL ONCOLOGY (2023)

添加到收藏夹

Review Cell Biology

Updates on Clinical Use of Liquid Biopsy in Colorectal Cancer Screening, Diagnosis, Follow-Up, and Treatment Guidance

Omayma Mazouji, Abdelhak Ouhajjou, Roberto Incitti, Hicham Mansour

Summary: Colorectal cancer is one of the most common cancers globally, with solid biopsy being an essential guide for clinical management, but liquid biopsy has shown significant promise as an alternative tool in various CRC clinical applications, such as early detection, treatment decision-making, and monitoring treatment response.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

添加到收藏夹

Article Oncology

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer

Ronan J. Kelly, Katherine Bever, Joseph Chao, Kristen K. Ciombor, Cathy Eng, Marwan Fakih, Lipika Goyal, Joleen Hubbard, Renuka Iyer, Holly T. Kemberling, Smitha Krishnamurthi, Geoffrey Ku, Mindy Mintz Mordecai, Van K. Morris II, Andrew Scott Paulson, Valerie Peterson, Manish A. Shah, Dung T. Le

Summary: Gastrointestinal (GI) cancers are a heterogeneous group of malignancies that impose a significant burden globally. Immunotherapy, specifically immune checkpoint inhibitors (ICIs), has transformed the treatment landscape for several GI cancers. However, ICIs have differing biomarker and histology requirements depending on the anatomic site of origin, and they are associated with unique toxicity profiles. To provide guidance to the oncology community, the Society for Immunotherapy of Cancer (SITC) developed a clinical practice guideline on immunotherapy for GI cancer.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI)

Jean Frederic Blanc, Audrey Debaillon-Vesque, Gael Roth, Jean Claude Barbare, Anne Sophie Baumann, Valerie Boige, Karim Boudjema, Mohamed Bouattour, Gilles Crehange, Barbara Dauvois, Thomas Decaens, Francois Dewaele, Olivier Farges, Boris Guiu, Antoine Hollebecque, Philippe Merle, Janick Selves, Thomas Aparicio, Isaac Ruiz, Olivier Bouche

Summary: This document summarizes the French Intergroup guidelines on the management of hepatocellular carcinoma (HCC) published in March 2019. Recommendations are graded in 3 categories based on the level of evidence from literature. Diagnosis and staging of HCC rely on clinical, biological, and imaging features, with treatment options varying based on tumor stage and liver function.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2021)

添加到收藏夹

Article Oncology

Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3

Sara Ballabio, Ilaria Craparotta, Lara Paracchini, Laura Mannarino, Silvia Corso, Maria Grazia Pezzotta, Martina Vescio, Robert Fruscio, Chiara Romualdi, Emanuele Dainese, Lorenzo Ceppi, Enrica Calura, Silvana Pileggi, Giulia Siravegna, Linda Pattini, Paolo Martini, Martina delle Marchette, Costantino Mangioni, Antonio Ardizzoia, Antonio Pellegrino, Fabio Landoni, Maurizio D'Incalci, Luca Beltrame, Sergio Marchini

INTERNATIONAL JOURNAL OF CANCER (2019)

添加到收藏夹

Article Oncology

Adult primary cervical rhabdomyosarcomas: A Multicentric cross-national case series

Enzo Ricciardi, Helmut Plett, Valentina Sangiorgio, Mariachiara Paderno, Fabio Landoni, Giovanni Aletti, Sonia Prader, Andreas du Bois, Philipp Harter, Nicoletta Colombo

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

添加到收藏夹

Article Oncology

Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study

Angiolo Gadducci, Stefania Cosio, Andrea Alberto Lissoni, Valentina Zizioli, Marco Adorni, Anna Maria Ferrero, Fabio Landoni, Enrico Sartori

ANTICANCER RESEARCH (2020)

添加到收藏夹

Article Oncology

Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison

Francesco Fanfani, Giorgia Monterossi, Maria Letizia Di Meo, Eleonora La Fera, Federica Dell'Orto, Alessandro Gioe, Maria Lamanna, Debora Ferrari, Elena De Ponti, Patrizia Perego, Stefano Restaino, Ronsini Carlo, Gian Franco Zannoni, Fabio Landoni, Giovanni Scambia, Alessandro Buda

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

添加到收藏夹

Article Oncology

European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer

David Cibula, Francois Planchamp, Daniela Fischerova, Christina Fotopoulou, Christhardt Kohler, Fabio Landoni, Patrice Mathevet, Raj Naik, Jordi Ponce, Francesco Raspagliesi, Alexandros Rodolakis, Karl Tamussino, Cagatay Taskiran, Ignace Vergote, Pauline Wimberger, Ane Gerda Zahl Eriksson, Denis Querleu

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

添加到收藏夹

Article Oncology

Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients

Cinzia Crivellaro, Claudio Landoni, Federica Elisei, Alessandro Buda, Manuela Bonacina, Tommaso Grassi, Lavinia Monaco, Daniela Giuliani, Irene Gotuzzo, Sonia Magni, Giampaolo Di Martino, Martina Delle Marchette, Luca Guerra, Fabio Landoni, Robert Fruscio, Cristina Messa, Elisabetta De Bernardi

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

添加到收藏夹

Article Oncology

Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers

Tommaso Grassi, Federica Dell'Orto, Marta Jaconi, Maria Lamanna, Elena De Ponti, Mariachiara Paderno, Fabio Landoni, Biagio Eugenio Leone, Robert Fruscio, Alessandro Buda

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

添加到收藏夹

Article Oncology

Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: A multi-institutional study

J. Casarin, A. Buda, G. Bogani, F. Fanfani, A. Papadia, M. Ceccaroni, M. Malzoni, A. Pellegrino, F. Ferrari, S. Greggi, S. Uccella, C. Pinelli, A. Cromi, A. Ditto, G. Di Martino, L. Pedone Anchora, F. Falcone, F. Bonfiglio, F. Odicino, M. Mueller, G. Scambia, F. Raspagliesi, F. Landoni, F. Ghezzi

GYNECOLOGIC ONCOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis

Lara Paracchini, Chiara Pesenti, Martina Delle Marchette, Luca Beltrame, Tommaso Bianchi, Tommaso Grassi, Alessandro Buda, Fabio Landoni, Lorenzo Ceppi, Cristina Bosetti, Mariachiara Paderno, Marco Adorni, Debora Vicini, Patrizia Perego, Biagio Eugenio Leone, Maurizio D'Incalci, Sergio Marchini, Robert Fruscio

JAMA NETWORK OPEN (2020)

添加到收藏夹

Article Oncology

Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic

Giorgio Bogani, Giovanni Scambia, Chiara Cimmino, Francesco Fanfani, Barbara Costantini, Matteo Loverro, Gabriella Ferrandina, Fabio Landoni, Luca Bazzurini, Tommaso Grassi, Domenico Vitobello, Gabriele Siesto, Anna Myriam Perrone, Vanna Zanagnolo, Pierandrea De Iaco, Francesco Multinu, Fabio Ghezzi, Jvan Casarin, Vito A. Capozzi, Errico Zupi, Gabriele Centini, Antonio Pellegrino, Silvia Corso, Guido Stevenazzi, Serena Montoli, Anna Chiara Boschi, Giuseppe Comerci, Pantaleo Greco, Ruby Martinello, Francesco Sopracordevole, Giorgio Giorda, Tommaso Simoncini, Marta Caretto, Enrico Sartori, Federico Ferrari, Antonio Cianci, Giuseppe Sarpietro, Maria Grazia Matarazzo, Fulvio Zullo, Giuseppe Bifulco, Michele Morelli, Annamaria Ferrero, Nicoletta Biglia, Fabio Barra, Simone Ferrero, Umberto Leone Roberti Maggiore, Stefano Cianci, Vito Chiantera, Alfredo Ercoli, Giulio Sozzi, Angela Martoccia, Sergio Schettini, Teresa Orlando, Francesco G. Cannone, Giuseppe Ettore, Andrea Puppo, Martina Borghese, Canio Martinelli, Ludovico Muzii, Violante Di Donato, Lorenza Driul, Stefano Restaino, Alice Bergamini, Giorgio Candotti, Luca Bocciolone, Francesco Plotti, Roberto Angioli, Giulia Mantovani, Marcello Ceccaroni, Chiara Cassani, Mattia Dominoni, Laura Giambanco, Silvia Amodeo, Livio Leo, Raphael Thomasset, Diego Raimondo, Renato Seracchioli, Mario Malzoni, Franco Gorlero, Martina Di Luca, Enrico Busato, Sami Kilzie, Andrea Dell'Acqua, Giovanna Scarfone, Paolo Vercellini, Marco Petrillo, Salvatore Dessole, Giampiero Capobianco, Andrea Ciavattini, Giovanni Delli Carpini, Luca Giannella, Liliana Mereu, Saverio Tateo, Flavia Sorbi, Massimiliano Fambrini, Stefania Cicogna, Federico Romano, Giuseppe Ricci, Giuseppe Trojano, Roberto Consonni, Simona Cantaluppi, Antonio Lippolis, Raffaele Tinelli, Giovanni D'Ippolito, Lorenzo Aguzzoli, Vincenzo D. Mandato, Stefano Palomba, Davide Calandra, Maurizio Rosati, Cinzia Gallo, Daniela Surico, Valentino Remorgida, Francesco Ruscitto, Paolo Beretta, Pierluigi Benedetti Panici, Raspagliesi Francesco

Summary: The COVID-19 pandemic has significantly impacted the characteristics and patterns of care for endometrial cancer (EC) patients, affecting their presentation and treatment. Changes were observed in diagnostic assessments, surgery, nodal assessment, and adjuvant therapy use during the pandemic. These findings highlight the importance of implementing healthcare services during the COVID-19 pandemic.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study

Marianna Martinelli, Chiara Giubbi, Illari Sechi, Fabio Bottari, Anna Daniela Iacobone, Rosario Musumeci, Federica Perdoni, Narcisa Muresu, Andrea Piana, Robert Fruscio, Fabio Landoni, Clementina Elvezia Cocuzza

Summary: This study aimed to evaluate the accuracy of self-samples using the BD Onclarity (TM) HPV assay on vaginal and first-void urine samples compared to clinician-collected samples. The results showed substantial agreement between self-collected and clinician-collected samples for both vaginal and urine samples.

DIAGNOSTICS (2022)

添加到收藏夹

Article Virology

Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy

Marianna Martinelli, Chiara Giubbi, Maria Letizia Di Meo, Federica Perdoni, Rosario Musumeci, Biagio Eugenio Leone, Robert Fruscio, Fabio Landoni, Clementina Elvezia Cocuzza

Summary: This study evaluated the accuracy of HPV testing using self-collected urine and vaginal samples, comparing them to physician-collected cervical swabs. The results showed significant concordance in high-risk HPV detection between self-collected samples and clinical counterparts. The study highlights the efficacy of self-sampling in detecting high-grade cervical lesions and emphasizes its role in increasing participation.

VIRUSES-BASEL (2023)

添加到收藏夹

Review Health Care Sciences & Services

Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors?

Rossella E. Nappi, Silvia Martella, Francesca Albani, Chiara Cassani, Ellis Martini, Fabio Landoni

Summary: Genitourinary syndrome of menopause (GSM) is a chronic condition that affects women's urogenital health and sexual function. Symptoms are often not reported or underestimated, leading to underdiagnosis and undertreatment. Local estrogen therapy is the mainstay of vaginal treatments, but it may not be suitable for women with a history of hormone receptor positive cancer. Hyaluronic acid-based moisturizers may be a safe and effective non-hormonal treatment option, especially for women with a history of cancer.

HEALTHCARE (2022)

添加到收藏夹

Article Oncology

Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer

Lara Paracchini, Luca Beltrame, Tommaso Grassi, Alessia Inglesi, Robert Fruscio, Fabio Landoni, Davide Ippolito, Martina Delle Marchette, Mariachiara Paderno, Marco Adorni, Marta Jaconi, Chiara Romualdi, Maurizio D'Incalci, Giulia Siravegna, Sergio Marchini

Summary: TF in plasma serves as an independent prognostic marker for disease progression and relapse in HGS-EOC patients. After platinum-based treatment, ctDNA analysis shows changes in genomic amplification patterns, with serially collected ctDNA samples' TF outperforming CA-125 in predicting disease progression.

CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Article Obstetrics & Gynecology

Onclarity Human Papillomavirus Extended Genotyping in the Management of Cervical Intraepithelial Neoplasia 2+Lesions

Fabio Bottari, Anna Daniela Iacobone, Sara Boveri, Eleonora Petra Preti, Dorella Franchi, Luciano Mariani, Mario Preti, Fabio Landoni, Rita Passerini, Maria Teresa Sandri

JOURNAL OF LOWER GENITAL TRACT DISEASE (2019)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.